TD Cowen raised the firm’s price target on UnitedHealth (UNH) to $338 from $335 and keeps a Hold rating on the shares. The firm updated its model as Q3 results checked a lot of boxes; adjusted EPS beat, FY25 guide raise, tax rate/investment income inline. They raise the target but keep the P/E target unchanged.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UNH:
- Positive Outlook for UnitedHealth: Strong Earnings Recovery and Strategic Positioning in Value-Based Care
- UnitedHealth price target raised to $440 from $433 at Bernstein
- UnitedHealth: Navigating 2026 Challenges with Strategic Growth Plans for a Promising 2027
- Moderately bullish activity in UnitedHealth with shares down 3.11%
- RBC Capital, Leerink Analysts Boost UnitedHealth Stock (UNH) Price Targets on Q3 Beat